{
    "2019-06-01": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Were Hedge Funds Right About Souring On Pfizer Inc. (PFE)?",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Souring",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis hopes Kisqali data will help narrow gap to blockbuster rival",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Kisqali",
                        "blockbuster",
                        "rival"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}